Oxford BioMedica Oxford BioMedica is a niche specialist in gene and cell therapy, with a leading position in lentiviral and cell therapy research, development and bioprocessing.
| Industry: | Health Care |
| Sector: | Health Care |
| Website: | www.oxb.com |
| Twitter: | @OxfordBiomedica |
| Exchange: | LSE |
| Admission date: | 29 May 2018 |
| Market: | Main Market |
| Region: | Europe |
No Results & Reports data for this company
| 20 Sep 2023 | Extended Analyst and Investor Briefing |
| 23 Jun 2023 | Annual General Meeting |
| 25 Apr 2023 | Analyst Briefing |
| 20 Apr 2023 | Analyst Briefing and Q&A Session |
| 15 Sep 2022 | Virtual Analyst Briefing |